Special interview with Chinese and international top neuro-ophthalmologists on LHON Awareness Day

Neurophth Secures Australian Approval for Ophthalmic Gene Therapy

Neurophth Announces First Patient Dosed in Phase I/II Clinical Trial of Second Gene Therapy

Special interview with Dr. Marcela Ciccioli

Neurophth Announces IND Approval by the NMPA for Second Gene Therapy NFS-02 (rAAV2-ND1)

Neurophth's Gene Therapy NR082 Completes Initiation of Multiple Clinical Research Centers in U.S.

Maltese Patient Received World's First ND1-LHON Gene Therapy Injection Donated by Neurophth in China

Commercialization of Gene Therapy is coming soon: Neurophth Completes Patient Enrollment for Phase III clinical trial for the gene therapy treatment of LHON

1st LHON INTERNATIONAL FORUM